Avitar to Present at American Stock Exchange Online Investor Conference

-- CEO Peter P. Phildius to Speak with Investment Community on June 19 --

June 14, 2001

CANTON, Mass., June 14 /PRNewswire/ -- Avitar, Inc. (Amex: - news) announced today that it will make a presentation at the American Stock Exchange Online Conference on Tuesday, June 19 at 2 p.m. ET.

During the conference, Peter P. Phildius, Avitar's Chairman and Chief Executive Officer will provide a corporate overview and discuss the company's strategy and vision. Avitar will be among more than 40 public companies presenting during the three-day conference for the investment community, who will be able to view the presentations online during the conference.

The event is co-sponsored by: StreetFusion, which reaches 15,000 buy-side and sell-side investors; Motley Fool, a financial forum with a market of 1.4 million individual investors; and Financial Relations Board. All three will help provide distribution to the retail, institutional and individual investor audiences.

Members of the investment community interested in listening to the Avitar presentation can do so by logging onto Avitar's website at avitarinc.com, and following the links to the conference. The presentation will then be archived on Avitar's website, as well as at amex.com and StreetFusion.com.

ABOUT AVITAR

Avitar, Inc. (Amex: - news) headquartered in Canton, Massachusetts, develops, manufactures and markets innovative medical devices based on proprietary core technologies for two distinctive markets: oral fluid diagnostics and customized polyurethane applications used in the wound dressing industry. Oral fluid diagnostics includes both the drugs-of-abuse testing market estimated to be worth $1.5 billion encompassing the corporate workplace and criminal justice markets and the $20 billion clinical diagnostics market. Avitar's products include ORALscreen(TM), the world's first non-invasive, rapid, onsite oral fluid test for drugs-of-abuse, and HAIRscreen(TM) a laboratory based hair test for detecting long-term drug abuse. Additionally, the company manufactures and markets HYDRASORB(TM), an absorbent topical dressing for moderate to heavy exudating wounds. In 2001, the company formed a strategic partnership with Pinkerton Security Group.

For more information, see Avitar's website at avitarinc.com.

This release contains forward looking statements that are subject to risks and uncertainties including the development and marketing of new applications and other risks that are detailed from time to time in the Company's filings with the Securities and Exchange Commission.